Kevin Chih-Yang Huang

26PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Feb 25, 2026
Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse.

Chi-Hsien Huang, Jhen-Yu Chen, Hsin-Yu Chang

|Feb 02, 2026
Targeting ENO1 reprograms macrophage polarization to trigger antitumor immunity and improves the therapeutic effect of radiotherapy.

Yu-Sen Lin, Hsin-Yu Chang, Wei-Ze Hong

|Aug 01, 2025
CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer.

Jhen-Yu Chen, Tao-Wei Ke, Shu-Fen Chiang

|Apr 21, 2025
Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy.

Tao-Wei Ke, Chia-Yi Chen, William Tzu-Liang Chen

|May 31, 2024
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers.

Kevin Chih-Yang Huang, William Tzu-Liang Chen, Jia-Yi Chen

|May 15, 2024
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy.

Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang

Pageof 5

Frequent Collaborators

18 joint publications

Kun-San Clifford Chao

5 joint publications

Shu-Fen Chiang

4 joint publications

Chih-Yang Huang

2 joint publications

Wei-Ze Hung